|
TCTE3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.996980E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.793380E-01 |
| Normal-vs-Stage2 |
3.571600E-02 |
| Normal-vs-Stage3 |
8.164500E-03 |
| Normal-vs-Stage4 |
4.199700E-03 |
| Stage1-vs-Stage2 |
1.421630E-01 |
| Stage1-vs-Stage3 |
7.988100E-02 |
| Stage1-vs-Stage4 |
2.522400E-02 |
| Stage2-vs-Stage3 |
9.899200E-01 |
| Stage2-vs-Stage4 |
4.041400E-01 |
| Stage3-vs-Stage4 |
3.620200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.427580E-02 |
| Normal-vs-AfricanAmerican |
4.584500E-04 |
| Normal-vs-Asian |
2.162800E-01 |
| Caucasian-vs-AfricanAmerican |
1.156320E-02 |
| Caucasian-vs-Asian |
4.494800E-01 |
| AfricanAmerican-vs-Asian |
8.149600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.372340E-02 |
| Normal-vs-Female |
2.457800E-03 |
| Male-vs-Female |
3.633800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.894600E-01 |
| Normal-vs-Age(41-60Yrs) |
2.919400E-03 |
| Normal-vs-Age(61-80Yrs) |
3.044400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.358020E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.474200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.835800E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.316600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.195600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.060200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.971200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
4.876000E-02 |
| Normal-vs-Grade 2 |
1.691990E-02 |
| Normal-vs-Grade 3 |
1.340130E-02 |
| Normal-vs-Grade 4 |
1.111430E-01 |
| Grade 1-vs-Grade 2 |
1.717220E-01 |
| Grade 1-vs-Grade 3 |
1.681240E-01 |
| Grade 1-vs-Grade 4 |
2.327600E-01 |
| Grade 2-vs-Grade 3 |
9.216400E-01 |
| Grade 2-vs-Grade 4 |
9.566200E-01 |
| Grade 3-vs-Grade 4 |
9.883400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.200000E-02 |
| Normal-vs-ccB subtype |
1.764440E-01 |
| ccA subtype-vs-ccB subtype |
6.235200E-01 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.447300E-04 |
| Normal-vs-N1 |
5.276000E-01 |
| N0-vs-N1 |
6.531000E-01 |
|
|
